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ABSTRACT 
A numerous novel drug delivery system has been emerged by combining herbal medicine with nanotechnology to administer drugs encompassing 
the enhancement of compatibility and efficacy. The herbal phytoconstituents are compatible compared to the chemical active pharmaceutical 
ingredients (APIs). But the therapeutic consequence of the phytoconstituent is limited due to poor aqueous solubility. Therefore, the demand to 
develop a system which improves the solubility of the phytomedicine is mounting rapidly. Nanotechnology plays a vital role in increasing the 
solubility, enhancing the bioavailability and improving the drug specificity of bioactive constituents. Nanosystems such as liposomes, nanoparticles, 
phytosomes, ethosomes, nanoemulsions and solid lipid nanoparticles are used to deliver the bioactive constituent at an adequate dose to the site of 
action and during the entire treatment period. The current review discusses the various novel drug delivery systems which have been developed to 
attain better therapeutic response of the herbal drug. 
Keywords: Bioavailability, Nanocarriers, Drug delivery, Ethnopharmacology, Phospholipid bilayer, Vesicular drug delivery 




Plants have long been recognized for their therapeutic properties. 
For centuries, aboriginal cultures around the world have used 
traditional herbal medicine to treat a myriad of diseases [1]. The 
demand for herbal medicines has surged recently due to its ability 
to treat diseases with negligible or lesser side effects [2]. There 
has been a chief concern using modern medicines in treating 
diseases like cancer using chemotherapy, hormone-blocking 
therapy, monoclonal antibodies, and their kinds. They create the 
aftermaths and adverse effects in addition to the therapeutic 
complications and cost. Ethnopharmacological medicines are an 
ideal alternate to these concerns.  
Some major water-insoluble phytoconstituents like flavonoids and 
tannins suffer from confines like poor water solubility, lipophilicity 
and inappropriate molecular size consequential in poor absorption 
and bioavailability [3]. But the technique by which a drug is 
transported can have a substantial consequence on its efficacy [4]. 
Hence, the research across the globe has begun to ponder on 
formulating the delivery system without having to change the nature 
of the phytoconstituents of the herbs. 
Various drug delivery systems and drug targeting approaches are now 
under progress to curtail drug deprivation, prevent destructive side-
effects and increase drug bioavailability [5, 6]. Some of the novel drug 
delivery approaches are effectual in improving the dissolution 
properties of poorly water-soluble drugs in accomplishing controlled 
drug delivery systems which delivers the drug at a rate dictated by the 
need of the body over a period of treatment at the site of action. 
Carrier-mediated drug delivery systems can be applied for herbal 
drugs to safe, effective and time-tested products [7]. The carriers can 
be made gradually degradable, prompt reactive and even targeted. 
Different types of nanomaterials are used as nanocarriers which 
permit hydrophobic and hydrophilic drugs to deliver throughout the 
body which can be either dissolved, entrapped or encapsulated to the 
polymer matrix to intensify the solubility, sustained release effects, can 
be protected from degradation and can even be targeted to the site of 
action [8, 9]. Therefore, various types of nanocarriers can be made up 
of natural and synthetic polymers, polysaccharides and lipids such as 
polymeric nanoparticles, solid lipid nanoparticles, liposomes and 
phytosomes for better therapeutic responses by integrating with 
traditional medicine system (fig. 1). These types of novel drug delivery 
systems enhance the solubility, bioavailability, stability, pharma-
cological activity of the drug molecule and also protect it from physical 
and chemical degradation. 
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Fig. 1: An overview of different drug carriers [4] 
 
Drug delivery systems are based on interdisciplinary approach, that 
slowly delivers drug at a controlled rate. They amend drug release 
profile, absorption, distribution and elimination thereby improving the 
product efficacy as well as the pharmacokinetic and pharmacodynamic 
characteristics of various drug molecules to potentially overcome the 
limitations of conventional therapeutics [10]. 
Nanoparticles 
Nanoparticles are colloidal systems whose particle size ranges from 10 
to 100 nm [11]. It has numerous advantages which includes enhanced 
solubility and bioavailability, size reduction and better absorption of 
herbal medicine [12]. This type of drug delivery system should be 
efficient enough to circulate in the bloodstream and to target cells and 
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tissues. They are also capable of releasing biologically active 
constituents to the site of action at a therapeutically optimal rate in a 
dose-dependent manner [13]. There are different biological and non-
biological methods of nanoparticle synthesis which is economical, eco-
friendly and also cost-effective [14-16].  
Raksha et al. formulated paclitaxel loaded nanoparticulate system 
which appears to be capable in carrying as well as targeted delivery 
of paclitaxel with enhanced therapeutic efficacy and safety thereby 
minimizing the adverse effects [17]. Khdair et al. developed novel 
chitosan-modified polymeric nanoparticles by double emulsion 
solvent evaporation technique which proficiently encapsulated 
anticancer drugs, and sustained the release, enhanced oral 
bioavailability, and improved tumour cellular uptake of the drugs 
[18]. Patricia et al. developed three different lignin nanoparticles 
which show better stability, biocompatibility, uniform dispersity, 
ability to load poorly soluble drugs, good cellular interaction and 
sustained drug release for disease diagnosis and therapy [19]. 
Jagminas et al. reported a novel method to synthesise methionine 
mediated super paramagnetic Cobalt ferrite nanoparticle linked with 
gold quantum dots which has promising application in targeted drug 
delivery [20]. Chen et al. inspected a pH-sensitive drug release 
system for targeting CD44 receptor using doxorubicin conjugated 
mesoporous silica nanoparticles which exhibited improved drug 
effectiveness and better stability at functional pH for novel 
preparation of drug delivery systems [21]. Villeret et al. Silver 
nanoparticles act as potential antivirals for treating human 
infectious disease i. e specifically influenza virus infection. It 
enhanced chemokine (C-C motif) 5 and interferon beta cytokines 
that might have practical implication in clinical application [22]. 
Liposomes 
Liposomes are lipid bilayers of 50-1000 nm in diameter that act as 
convenient vehicles to deliver biologically active agents [23]. They 
are usually made up of phospholipids which can incorporate both 
hydrophilic and lipophilic molecules [24, 25]. They improve drug 
solubility, bioavailability and stability. They can even combine with 
site-specific ligands to attain active targeting. They also enhance the 
therapeutic activity and safety of drugs chiefly by delivering them at 
the site of action and by sustaining the therapeutic levels of drug for 
a prolonged period of time [26, 27]. 
Hadis et al. reported that the liposomes are one of the most 
advanced and reliable techniques for the progress of useful 
bioproducts particularly in medical diagnostics [28]. Maussang et al. 
formulated PEGylated liposomes conjugate with glutathione for 
safely deliver the encapsulated drugs to the brain which serve as 
promising drug delivery technology for the treatment of CNS 
disorders [29]. Xiao et al. developed sorafenib and gadolinium co-
loaded liposomes to improve the sparsely water soluble sorafenib 
and to screen its distribution and the early response on its in vivo 
treatment in a precise manner and found that this could be a 
promising nano-carrier for the MRI-guided in vivo visualization of 
the delivery and Hepatocellular carcinoma treatment [30]. Sharma et 
al. proposed an advanced approach to target C-typed lectin receptor 
through nanoliposome by mannose surface modification for active 
targeting which is a promising system for effective cancer 
immunotherapy [31]. Abraham et al. prepared a safe and efficient 
nanoliposome for the proper delivery of therapeutic mRNA for 
treating various diseases such as cancer, inflammatory as well as 
cardiovascular diseases [32]. Ju et al. studied octreotide altered 
daunorubicin conjugated liposomes loaded with dihydroartemisinic 
that showed improved cellular uptake and cytotoxicity while 
evaluated on breast cancer cells and xenografts nude mice models 
[33]. Tatodeet al. used response surface methodology to formulate 
paclitaxel-loaded liposomes by thin film hydration method which 
demonstrates better enhancement of in-vitro drug release [34]. 
Nanoemulsions 
Nanoemulsions are also called as oil-in-water emulsions composed 
of oil droplets and stabilized by surfactants [35, 36]. The average 
size of the oil droplet in nanoemulsion is between 100 and 500 nm. 
It is prepared by mixing oil phase with an aqueous phase under high 
mechanical extrusion process [37, 38]. Both hydrophilic and 
lipophilic molecules can be efficiently incorporated. This is one of 
the efficient systems for enhancing drug delivery.  
Zheng et al. integrated nanoemulsions into hydrogels which shows 
great potential for therapeutic purposes through topical or systemic 
administration. They also claimed that the prepared nanoemulsion 
is more stable and safe [39]. Mou et al. developed nanoemulsion gel-
based topical delivery of Amphotericin which is an economic 
approach for enhanced and sustained permeation of drug against 
fungal assessment [40]. Primo et al. denominated magnetic 
nanoemulsion which enhances the diffusion of the drug when 
associated with Foscanfor the application of photodynamic therapy 
[41]. Mahato et al. reported that nanoemulsionsserve as the effective 
drug delivery as a carrier of nucleic acids, drugs as well as imaging 
agent which has been widely used for disease diagnostics, imaging 
and therapy [42]. Jasmina et al. prepared nanoemulsions by both 
higher energy and lower energy emulsion methods and concluded 
that low energy methods are greatly recognized by the 
manufacturers as they do not require any expensive equipment [43]. 
Wu et al. determined the absorption mechanism ofBaicalin mediated 
nanoemulsion by in situ single-pass intestine perfusion (SPIP) 
method and chylomicron-blocked rat model for effectual oral 
delivery [44]. Gueutin et al. evaluated erythromycin loaded 
nanoemulsion by hot high-pressure homogenization method which 
increases the stability of erythromycin in an acidic condition as it 
acts as a suitable system for Helicobacter pylori treatment [45]. 
Phytosome 
Phytosome is also known as phytolipids delivery system which 
forms a bridge between the conventional drug delivery system and 
novel drug delivery system. The polyphenolic phytoconstituents are 
complexed with phospholipid to produce lipid compatible molecular 
complexes in the equimolar ratio [46]. They improve the absorption 
of poorly water-soluble drugs through various routes of 
administration thereby increasing the bioavailability and 
therapeutic index when compared to traditional drug delivery 
systems [47, 48]. They also enhance the capacity of drugs to cross 
the lipid bilayer thereby reaching the systemic circulation [49]. 
Chetan et al. reported that phytosome shows improved 
pharmacokinetic and pharmacodynamic effect than conventional 
botanical extracts which can be utilized for treating various diseases 
[50]. The prepared phytosome using sinigrin shows higher efficiency 
than control to release the compound in a slow and controlled 
manner into the stratum corneum for wound healing [51]. 
Abdelkader et al. formulated L-carnosine phytosome by combining 
hydrogel and lipid-based carrier which shows sustained drug 
pervasion and inhibits the browning of the lens and protects from 
cataract formation [52]. Damle et al. focused on encapsulating 
orange peel and liquorice extracts into phospholipid complex which 
exhibited as a better topical dosage delivery towards skin that 
ensured high cutaneous absorption of phytoconstituents in the skin 
for long period of action in contradiction to skin ageing [53]. Das et 
al. proposed the synthesized rutin-phytosome complex increases the 
transdermal absorption rate to treat various diseases such as 
arthritis, rheumatism, etc. with controlled and sustained drug 
release [54]. The lyophilized technique was found to be more 
efficient to deliver diosmin when compared to other methods 
(solvent evaporation, salting out) of phytosomal preparation as it 
enhances the absorption and permeation of the drugs across the 
lipid bilayer as described by May et al. [55]. Telange et al. conjugated 
apigenin, a low aqueous soluble compound with phospholipid which 
act as an excellent potential to improve the in vivo antioxidant 
activity, solubility, bioavailability and pharmacological properties 
compared to free apigenin [56]. 
Ethosomes 
Ethosomesare non-invasive lipid vesicular carrier system in which it 
composed of phospholipid increased the concentration of alcohol 
(mostly ethanol) and water [57]. High concentration of alcohol 
makes this system more unique. They effectively incorporate the 
delivery of lipophilic, hydrophilic and amphiphilic molecules to the 
body [58]. They promote high entrapment efficiency, better stability 
and controlled release of drugs through transdermal route to the 
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systemic circulation [59]. They tend to be more superior than 
liposome as it delivers drug through the skin in terms of quantity 
and level of penetration [60].  
Sharma et al. developed phospholipid-based carrier systems for the 
effective delivery of Aceclofenac and found that ethosome prepared by 
cold method offers high vesicle density and drug loading efficiency as 
compared with elastic membrane vesicles [61]. Shelke et al. optimized 
Zolmitriptan loaded ethosomal intranasal gel by three-level factorial 
design which could aid as an effective therapy for the recurrence of a 
migraine with controlled release and permeability [62]. Sujatha et al. 
observed the release of fiasterideethosome was first order kinetics 
with higuchi diffusion mechanism which plays a promising role in 
transdermal drug delivery [63]. Jain et al. formulated the ethosome 
loaded with Carbopol as hydrogel and evaluated the in vitro 
permeation studies using rat skin which facilitate effective carrier for 
the transdermal route of drug administration [64]. Ahmed et al. aimed 
to optimize the ethosomal formulation made up of glimepiride and 
integrating them into transdermal films can reduce side effects and 
prolong the drug release [65]. Shaik et al. explored Aceclofenac loaded 
ethosomeincreases the transdermal flux and serve as an effectual 
vehicle for the sustained release of the drug. They also optimized the 
ethanol and lecithin concentration to improve the skin permeability 
and concluded that increased ethanol enhances the drug diffusion 
[66]. Milind et al. developed ethosome for topical delivery of 
rizatriptan benzoate as site-specific approach and optimized for 
maximum entrapment efficiency [67]. 
Solid lipid nanoparticles 
Solid lipid nanoparticles are spherical lipid particles remains in a solid 
state at room temperature [68]. Their size ranges from 50-1000 nm 
and are dispersed in aqueous surfactant solution [69]. Lipids used in 
the preparation of solid lipid nanoparticle can be stabilized by adding a 
biocompatible surfactant in the proper ratio [70]. They are generally 
made up of the hydrophobic core to which a monolayer of 
phospholipid is coated [71]. They have a tendency to carry both the 
hydrophilic and hydrophobic drugs for therapeutic purposes.  
Kotmakç et al. synthesised small solid lipid nanoparticles below 100 
nm by modified microemulsion method which exhibits lower 
toxicity on L929 cells for effective drug delivery [72]. Bhupinder et 
al. developed Acyclovir Solid Lipid Nanoparticles by high-pressure 
hot-homogenization technique were found to be the average size in 
nano range. It exhibited better entrapment efficiency and drug 
loading capacity in drug distribution pattern [68]. Thakkar et al. 
combined aspirin and curcumin with free sulforaphane entrapped 
chitosan solid lipid nanoparticle indicates the prolonged exposure of 
the developed formulation that act as effective therapy to prevent 
pancreatic cancer [73]. Chantaburananet al. developed Ibuprofen-
loaded solid lipid nanoparticle composed of different ratios of 
Softisan 378 and Cetyl palmitate which were found to have 
sustained release, decreased in particle size and surface charge of 
the particle for improved dermal drug delivery [74]. Wang et al. 
prepared ultra-fine powder using polysaccharide coated solid lipid 
nanoparticles and nanostructured lipid carrier by nanospray drying 
technology which can tend to produce uniform spherical lipid 
particle for improved lipid delivery system [75]. Mosallaeiet al. 
formulated solid lipid nanoparticle and PEGylated solid lipid 
nanoparticle containing 7-Ethyl-10-hydroxycamptothecin, an active 
component of irinotecan shows improved activity to hinder the 
occurrence of a tumour [76]. Chetoni et al. determined tobramycin 
as ion-pair combined with solid lipid nanoparticles for the treatment 
of ocular infections which favour the drug activity to effectively 
reach the inner parts of the eye [77]. The pharmacokinetic and 
biodistribution analysis of thymoquinone loaded solid lipid 
nanoparticle exposed that the formulation capably targets the brain 
and delivers the drug in a controlled manner to the target organ. It 
shows that Bioavailability and plasma half-life of TQ-SLNs 
significantly increased than TQ suspensions [78]. 
CONCLUSION 
Nanotechnology has been recognized for natural bioactive 
compounds to safely transport drugs into systemic circulation 
through various novel drug delivery systems. They have a tendency 
to exploit various biological compounds which have poor solubility, 
permeability and bioavailability. Hence, novel drug delivery systems 
can be used to improve the potent of biological compounds thereby 
avoiding the first pass effect, dose frequency and side effects at low 
cost. Thus, the progress of nanotechnology clutches the great 
potential to improve the therapeutic approach in the development of 




All the author has contributed equally 
CONFLICT OF INTERESTS 
Declared none 
REFERENCES 
1. Li FS, Weng JK. Demystifying traditional herbal medicine with a 
modern approach. Nature Plants 2017;3:17109. 
2. Priyanka P, Brahmeshwar M. Systematic review on interaction 
studies of synthetic antidiabetic drugs and herbal therapies. J 
Pharma Res 2017;16:86.  
3. Tanmoy S, Buddhadev L, Swayam P. Incorporation of lipolysis 
in monolayer permeability studies of lipid-based oral drug 
delivery systems. Drug Delivery Transl Res 2017;17:1-12. 
4. Nalini T, Sugantha Kumari V, Khaleel Basha S. Novel 
nanosystems for herbal drug delivery. World J Pharm Pharm 
Sci 2017;6:1447-63. 
5. Kusum D, Nimisha J, Kusum SV. Importance of novel drug delivery 
systems in herbal medicines. Pharmacogn Rev 2010;4:27–31. 
6. Fred L, Holger MR. Novel drug delivery systems tailored for 
improved administration of glucocorticoids. Int J Mol 
Sci 2017;18:1836. 
7. Shweta P, Niraj G, Manish J. Carrier-mediated target drug 
delivery systems: a novel approach-(An overview). Int J Pharm 
Pract 2013;4:701-9. 
8. Zhang L, Radovic-Moreno AF, Alexis F, Gu FX, Basto PA, 
Bagalkot V, et al. Co-delivery of hydrophobic and hydrophilic 
drugs from nanoparticle-aptamer bioconjugates. Chem Med 
Chem 2007;2:1268-71. 
9. Zhang G, Chan W, Langer F. Nanoparticles in medicine: 
therapeutic applications and developments. Clin Pharmacol 
Ther 2008;5:761-9. 
10. Sarika P, Ashutosh B, Deepak S. Sustained release matrix 
technology and recent advance in the matrix drug delivery 
system: a review. Int J Drug Res Technol 2017;3:8. 
11. Dan G, Guoxin X, Jianbin Luo. Mechanical properties of 
nanoparticles: basics and applications. J Phys D 2013;47:13.  
12. Wengang Li, Xiuhua Z, Xiaoli S, Yuangang Zu, Ying L, Yunlong 
GE. Evaluation of antioxidant ability in vitro and bioavailability 
of trans-cinnamic acid nanoparticle by liquid antisolvent 
precipitate. J Nanomater 2016;29:16. 
13. Akanksha Raj, Prasanna Shah, Namita Agrawa. Dose-dependent 
effect of silver nanoparticles (AgNPs) on fertility and survival 
of Drosophila: an in vivo study. J Nanomater 2017;5:124-31. 
14. Kiranmai M. Biological and non-biological synthesis of metallic 
nanoparticles: scope for current pharmaceutical research. 
Indian J Pharm Sci 2017;79:501-12. 
15. Pantidos N, Horsfall LE. Biological synthesis of metallic 
nanoparticles by bacteria, fungi and plants. J Nanomed 
Nanotechnol 2014;5:2157-79. 
16. Priyanka S, Yu-Jin K, Dabing Z, Deok-Chun Y. Biological 
synthesis of nanoparticles from plants and microorganisms. 
Trends Biotechnol 2016;34:588-99.  
17. Raksha G, Rakesh Kumar T, Anil Kumar M, Krishna C, Narendra 
Kumar J. Luteinizing hormone-releasing hormone peptide 
tethered nanoparticulate system for the enhanced antitumoral 
efficacy of paclitaxel. Nanomed 2016;7:588-99. 
18. Khdair A, Hamad I, Alkhatib H, Bustanji Y, Mohammad M, 
Tayem R, et al. Modified-chitosan nanoparticles: Novel drug 
delivery systems improve oral bioavailability of doxorubicin. 
Eur J Pharm Sci 2016;93:38-44. 
Sudarshanadeepa et al. 
Int J App Pharm, Vol 10, Issue 4, 2018, 26-30 
 
29 
19. Patricia F, Kalle Lintinen AK, Ville H, Zehua L, Tomas BR, Antti 
R, et al. In vitro evaluation of biodegradable lignin-based 
nanoparticles for drug delivery and enhanced antiproliferation 
effect in cancer cells. Biomat 2017;121:97-108. 
20. Jagminas A. Methionine-mediated synthesis of magnetic 
nanoparticles and functionalization with gold quantum dots for 
theranostic applications. J Nanotechnol 2017;8:1734-41.  
21. Chen C, Sun W, Wang X, Wang Y, Wang P. pH-responsive 
nanoreservoirs based on hyaluronic acid end-capped 
mesoporous silica nanoparticles for targeted drug delivery. Int 
J Biol Macromol 2018;17:33559-66. 
22. Villeret B, Dieu A, Straube M, Solhonne B, Miklavc P, Hamadi 
S, et al. Silver nanoparticles impair retinoic acid-inducible gene 
i mediated mitochondrial anti-viral immunity by blocking the 
autophagic flux in lung epithelial cells. ACS Nano 2018;2:1-49.  
23. Lisa S, Tejaswi V, Fatemeh M, Sherry YW, Anil KS, Susan H. 
Advances and challenges of liposome assisted drug delivery. 
Front Pharmacol 2015;6:286-92. 
24. Yoshihiro T, Kaoru N, Yurina I, Fumie H. Enhancement of skin 
penetration of hydrophilic and lipophilic compounds by ph-
sensitive liposomes. J Pharm Pharm Sci 2015;18:249-57. 
25. Maria C, Nikolaos N, Natassa P. The significance of drug-to-lipid 
ratio to the development of optimized liposomal formulation. J 
Liposome Res 2017;18:1-36. 
26. Ravi TPU, AbulKalam AM. Sustained release of green tea 
polyphenols from liposomal nanoparticles; release kinetics and 
mathematical modelling. Iranian J Biotech 2017;15:1322-41. 
27. Durgavati Y, Kumar S, Deepak P, Ranu Kumari D. Liposomes for 
drug delivery. J Biotechnol Biomater 2017;7:4. 
28. Hadis D, Ali E, Mohammad K, Samira A, Abolfazl A. Application 
of liposomes in medicine and drug delivery. Artif Cells 
Nanomed Biotechnol 2016;44:381-91. 
29. Maussang D, Rip J, Kregten J, Den Heuvel A,  Der Pol S,  Der 
Boom B, et al. Glutathione conjugation dose-dependently 
increases brain-specific liposomal drug delivery in vitro and in 
vivo. Drug Discovery Today: Technol 2016;20:59-69.  
30. Xiao Y, Liu Y, Yang S, Zhang B, Wang T, Jiang D, et al. Sorafenib 
and gadolinium co-loaded liposomes for drug delivery and 
MRI-guided HCC treatment. Colloids Surf 2016;141:83-92. 
31. Sharma R, Mody N, Kushwah V, Jain S, Vyas SP. C-type lectin 
receptor(s)-targeted nanoliposomes: an intelligent approach for 
effective cancer immunotherapy. Nanomed 2017;16:1945-59. 
32. Abraham MK, Peter K, Michel T, Wendel HP, Krajewski S, Wang X. 
Nanoliposomes for safe and efficient therapeutic mRNA delivery: a 
step toward nanotheranostics in inflammatory and cardiovascular 
diseases as well as cancer. Nanotheranostics 2017;2:154-65. 
33. Ju RJ, Cheng L, Peng XM, Wang T, Li CQ, Song XL, et al. 
Octreotide-modified liposomes containing daunorubicin and 
dihydroartemisinin for treatment of invasive breast cancer. 
Artif Cells Nanomed Biotechnol 2018;30:1-13.  
34. Tatode A, Patil A, Umekar M. Application of response surface 
methodology in the optimization of paclitaxel liposomes prepared 
by thin film hydration technique. Int J Appl Pharm 2018;10:62-9. 
35. Hasani F, Pezeshki A, Hamishehkar H. Effect of surfactant and 
oil type on size droplets of betacarotene-bearing 
nanoemulsions. Int J Curr Microbiol Appl Sci 2015;4:146-55.  
36. Wulff-Perez MA, Torcello-Gomez MJ, Galvez-Ruiz Martin-
Rodriguez. Stability of emulsions for parenteral feeding: 
Preparation and characterization of o/w nanoemulsions with 
natural oils and Pluronic f68 as a surfactant. Food Hydrocoll 
2009;23:1096-102. 
37. Lovelyn C, Anthony AA. Nanoemulsion, mechanical stress 
current state of nanoemulsions in drug delivery. J Biomater 
Nanobiotechnol 2011;2:626-39. 
38. Parthasarathi S, Muthukumar SP, Anandharamakrishnan C. The 
influence of droplet size on the stability, in vivo digestion, and 
oral bioavailability of vitamin E emulsions. Food 
Funct 2016;7:2294-302.  
39. Zheng Y, Ouyang WQ, Wei YP, Syed SF, Hao CS, Wang BZ, et al. 
Effects of carbopol® 934 proportion on nanoemulsion gel for 
topical and transdermal drug delivery: a skin permeation 
study. Int J Nanomed 2016;11:5971-87. 
40. Mou D, Chen H, Du D, Mao C,  Wan J, Xu H, et al. Hydrogel-
thickened nanoemulsion system for topical delivery of 
lipophilic drugs. Int J Pharm 2008;353:270-6. 
41. Primo FL, Michieleto L, Rodrigues MA, Macaroff PP, Morais PC, 
Lacava ZG, et al. Magnetic nanoemulsions as drug delivery 
system for Foscan®: Skin permeation and retention in vitro 
assays for topical application in photodynamic therapy (PDT) 
of skin cancer. J Magn Magn Mater 2007;311:354-7.  
42. Mahato R. Nanoemulsion as targeted drug delivery system for 
cancer therapeutics. J Pharm Sci Pharmacol 2017;3:83-97. 
43. Jasmina H, Dzana O, Alisa E, Edina V, Ognjenka R. Preparation 
of nanoemulsions by high-energy and low-energy 
emulsification methods. In CMBEBIH Springer; 2017. p. 317-22. 
44. Wu L, Bi Y, Wu H. Formulation optimization and the absorption 
mechanisms of nanoemulsion in improving baicalin oral 
exposure. Drug Dev Ind Pharm 2017;12:1-32. 
45. Gueutin C, Frebourg G, Burucoa C, Faivre V. Erythromycin 
encapsulation in nanoemulsion-based delivery systems for 
treatment of helicobacter pylori infection: protection and 
synergy. Biochem Biophys Res Commun 2017;493:146-51. 
46. Jain N, Gupta BP, Thakur N, Jain R, Banweer J, Jain DK, et al. 
Phytosome: a novel drug delivery system for herbal medicine. 
Int J Pharm Sci Drug Res 2010;2:224-8. 
47. Khan J, Alexander A, Saraf S, Saraf S. Recent advances and 
future prospects of phyto-phospholipid complexation 
technique for improving pharmacokinetic profile of plant 
actives. J Controlled Release 2013;68:50-60.  
48. Nanavati B. Phytosome: a novel approach to enhance the 
bioavailability of phytoconstituent. Asian J Pharm 
2017;11:S453-S461. 
49. Pawar HA, Bhangale BD. Phytosome as a novel biomedicine: a 
microencapsulated drug delivery system. J Bioanal Biomed 
2017;7:6-12. 
50. Chetan K, Hatware K. Phytosomes-novel drug delivery system. 
Ind J Drugs 2017;5:16-36. 
51. Mazumder A, Dwivedi A, Fox LT, Brummer A, Preez JL, Gerber 
M, et al. In vitro skin permeation of sinigrin from its 
phytosomecomplex. J Pharm Pharmacol 2016;68:1577-83.  
52. Abdelkader H, Longman MR, Alany RG, Pierscionek B. 
Phytosome-hyaluronic acid systems for ocular delivery of L-
carnosin. Int J Nanomed 2016;11:2815-27. 
53. Damle M, Mallya R. Development and evaluation of a novel 
delivery system containing phytophospholipid complex for 
skin aging. AAPS PharmSciTech 2016;17:607-17. 
54. Das MK, Kalita B. Design and evaluation of phyto-phospholipid 
complexes (Phytosomes) of rutin for transdermal application. J 
Appl Pharma Sci 2014;4:51-7. 
55. May S, Freag Yosra SR, Elnaggar Ossama Y, Abdallah. 
Lyophilized phytosomal nanocarriers as platforms for 
enhanced diosmin delivery: optimization and ex vivo 
permeation. Int J Nanomed 2013;8:2385-97. 
56. Telange DR, Patil AT, Pethe AM, Fegade H, Anand S, Dave VS. 
Formulation and characterization of an apigenin-phospholipid 
phytosome (APLC) for improved solubility, in vivo bioavailability, 
and antioxidant potential. Eur J Pharm Sci 2016;108:1-14. 
57. Pathan IB, Jaware BP, Shelke S, Ambekar W. Curcumin loaded 
ethosomes for transdermal application: formulation, 
optimization, in vitro and in vivo study. J Drug Delivery Sci 
Technol 2018;44:49-57. 
58. Khan NR, Wong TW. 5-Fluorouracil ethosomes–skin deposition 
and melanoma permeation synergism with microwave. Artif 
Cells Nanomed Biotechnol 2018;14:1-10. 
59. Zhang Y, Ng W, Hu J, Mussa SS, Ge Y, Xu H. Formulation and in 
vitro stability evaluation of ethosomal carbomer hydrogel for 
transdermal vaccine delivery. Colloids Surf B 2018;163:184-91. 
60. Lembo D, Donalisio M, Civra A, Argenziano M, Cavalli R. 
Nanomedicine formulations for the delivery of antiviral 
drugs: A promising solution for the treatment of viral 
infections. Expert opinion on drug delivery. Int J Pharm 
2018;15:93-114. 
61. Sharma G, Goyal H, Thakur K, Raza K, Katare OP. Novel elastic 
membrane vesicles (EMVs) and ethosomes-mediated effective 
topical delivery of aceclofenac: a new therapeutic approach for 
pain and inflammation. Drug Delivery 2016;23:3135-45. 
62. Shelke S, Shahi S, Jalalpure S, Dhamecha D. Poloxamer 407-based 
intranasal thermoreversible gel of zolmitriptan-loaded 
nanoethosomes: formulation, optimization, evaluation and 
permeation studies.  J Liposome Res 2016;26:313-23. 
Sudarshanadeepa et al. 
Int J App Pharm, Vol 10, Issue 4, 2018, 26-30 
 
30 
63. Sujatha S, Sowmya G, Chaitanya M, Reddy VK, Monica M, Kumar 
KK, et al. Preparation, characterization and evaluation of 
finasteride ethosomes. Int J Drug Delivery 2016;8:1-11.  
64. Jain S, Patel N, Madan P, Lin S. Formulation and rheological 
evaluation of ethosome-loaded carbopol hydrogel for 
transdermal application. Drug Dev Ind Pharm 2015;42:1315-24. 
65. Ahmed TA, Khalid M, Aljaeid BM, Fahmy UA, Abd-Allah FI. 
Transdermal glimepiride delivery system based on optimized 
ethosomalnano-vesicles: preparation, characterization, in vitro, 
ex vivo and clinical evaluation. Int J Pharm 2016;2:245-54.  
66. Shaik MR, Sadhana C, Pragathi S, Pranithanjali KR, Pavani B, 
Reddy TP. Formulation and in vitro evaluation of aceclofenac 
ethosomes. Indo Am J Pharm 2016;2:35-41. 
67. Milind P, Swati S. Development and optimization of rizatriptan 
benzoate ethosomes. Int J Appl Pharm 2018;10:83-90. 
68. Owuor JJ, Oloo F, Ouma D, Omwoyo WN, Gathirwa JW. 
Optimization and characterization of primaquine-loaded solid 
lipid nanoparticles (SLN) for liver schinonticide targeting by 
freeze drying. MOJ Drug Des Delivery Ther 2017;4:21-9. 
69. Bhupinder K, Newton MJ. Acyclovir solid lipid nanoparticles for 
skin drug delivery: fabrication, characterization and in vitro 
study. Recent Pat Drug Delivery 2017;11:132-46. 
70. Jannin V, Blas L, Chevrier S, Miolane C, Demarne F, Spitzer D. 
Evaluation of the digestibility of solid lipid nanoparticles of 
glyceryl dibehenate produced by two techniques: 
ultrasonication and spray-flash evaporation. Eur J Pharm Sci 
2018;111:91-5. 
71. Cirri M, Mennini N, Maestrelli F, Mura P, Ghelardini C, Mannelli 
LD. Development and in vivo evaluation of an innovative 
“Hydrochlorothiazide-in cyclodextrins-in solid lipid 
nanoparticles” formulation with sustained release and 
enhanced oral bioavailability for potential hypertension 
treatment in pediatrics. Int J Pharm 2017;521:73-83. 
72. Kotmakçı M, Akbaba H, Erel G, Ertan G, Kantarcı G. Improved 
method for solid lipid nanoparticle preparation based on hot 
microemulsions: preparation, characterization, cytotoxicity, 
and hemocompatibility evaluation. AAPS Pharm Sci Tech 
2017;18:1355-65. 
73. Thakkar A, Chenreddy S, Thio A, Khamas W, Wang J, Prabhu S. 
Preclinical systemic toxicity evaluation of chitosan-solid lipid 
nanoparticle-encapsulated aspirin and curcumin in 
combination with free sulforaphane in BALB/c mice. Int J 
Nanomed 2016;11:3265-76. 
74. Chantaburanan T, Teeranachaideekul V, Chantasart D, 
Jintapattanakit A, Junyaprasert VB. Effect of binary solid lipid 
matrix of wax and triglyceride on lipid crystallinity, drug-lipid 
interaction and drug release of ibuprofen-loaded solid lipid 
nanoparticles (SLN) for dermal delivery. J Colloid Interface Sci 
2017;504:247-56. 
75. Wang T, Hu Q, Zhou M, Xue J, Luo Y. Preparation of ultra-fine 
powders from polysaccharide-coated solid lipid nanoparticles 
and nanostructured lipid carriers by innovative nanospray 
drying technology. Int J Pharm 2016;511:219-22. 
76. Mosallaei N, Mahmoudi A, Ghandehari H, Yellepeddi VK, Jaafari 
MR, Malaekeh-Nikouei B. Solid lipid nanoparticles containing 7-
ethyl-10-hydroxycamptothecin (SN38): preparation, 
characterization, in vitro, and in vivo evaluations. Eur J Pharm 
Sci 2016;104:42-50. 
77. Chetoni P, Burgalassi S, Monti D, Tampucci S, Tullio V, Cuffini 
AM, et al. Solid lipid nanoparticles as a promising tool for 
intraocular tobramycin delivery: Pharmacokinetic studies on 
rabbits. Eur J Pharma Biopharm 2016;109:214-23.  
78. Surekha R, Sumathi T. An efficient encapsulation of 
thymoquinone using solid lipid nanoparticle for brain-targeted 
drug delivery: physicochemical characterization, pharmaco-
kinetics and biodistribution studies. Indian J Pharm Clin Res 
2016;8:1616-24. 
 
